000 01376 a2200337 4500
005 20250516030541.0
264 0 _c20120213
008 201202s 0 0 eng d
022 _a1535-2900
024 7 _a10.2146/ajhp090664
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBerhoune, Malik
245 0 0 _aEffect of requiring advance approval of chemotherapy on number and cost of ungiven doses.
_h[electronic resource]
260 _bAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
_cApr 2011
300 _a557-8 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCosts and Cost Analysis
650 0 4 _aDrug Compounding
_xeconomics
650 0 4 _aFrance
650 0 4 _aHumans
650 0 4 _aPharmacy Service, Hospital
_xeconomics
700 1 _aAboudagga, Haïl
700 1 _aJacob, Aude
700 1 _aGrandhaye, Jean-Pierre
700 1 _aDayot, Corinne
700 1 _aPrognon, Patrice
700 1 _aBonan, Brigitte
773 0 _tAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
_gvol. 68
_gno. 7
_gp. 557-8
856 4 0 _uhttps://doi.org/10.2146/ajhp090664
_zAvailable from publisher's website
999 _c20682799
_d20682799